PT  - JOURNAL ARTICLE
AU  - Forster, Martin
AU  - Felip, Enriqueta
AU  - Majem, Margarita
AU  - Doger, Bernard
AU  - Clay, Tim
AU  - Carcereny, Enric
AU  - Bondarenko, Igor
AU  - Peguero, Julio
AU  - Dols, Manuel Cobo
AU  - Ursol, Grygorii
AU  - Kalinka, Ewa
AU  - Ledo, Gema Garcia
AU  - Martinez, Laia Vilà
AU  - Krebs, Matthew
AU  - Iams, Wade T
AU  - Mueller, Christian
AU  - Brignone, Chrystelle
AU  - Triebel, Frederic
TI  - 595 Biomarker results from the 1st line non-small cell lung cancer cohort of TACTI-002: pharmacodynamic effects of combining eftilagimod alpha (soluble LAG-3) and pembrolizumab
AID  - 10.1136/jitc-2023-SITC2023.0595
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A677--A677
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A677.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A677.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.